Minor cannabinoids refer to the lesser-known compounds found in the cannabis plant alongside the well-known THC (tetrahydrocannabinol) and CBD (cannabidiol). These cannabinoids, such as CBG (cannabigerol), CBC (cannabichromene), and others, are gaining attention for their potential health benefits, including anti-inflammatory, analgesic, and neuroprotective properties. The minor cannabinoids market is experiencing significant growth driven by increasing consumer awareness and demand for alternative therapeutic options beyond THC and CBD.

The minor cannabinoids market is expanding due to regulatory changes favouring cannabis research and product development. Companies are investing in research to explore the therapeutic potential of these compounds, driving innovation in formulations and delivery methods. This sector presents opportunities for pharmaceutical applications, wellness products, and niche consumer goods catering to specific health needs. Key growth drivers include expanding legalization of cannabis products, growing acceptance of medical cannabis, and advancements in extraction and synthesis technologies. The trend towards natural and plant-based remedies further supports market expansion, offering opportunities for companies to differentiate through unique cannabinoid formulations and targeted health benefits.

In Terms of Revenue, the Global Minor Cannabinoids Market was Worth US$ 17.8 Bn in 2023, Anticipated to Witness CAGR of 8.2% During 2024 – 2034.

Growth Drivers of Global Minor Cannabinoids Market

• Expansion of Legalization and Regulatory Support: The legalization of cannabis for medical and recreational use across various regions is a significant driver propelling the minor cannabinoids market. As more jurisdictions recognize the therapeutic potential of cannabinoids beyond THC and CBD, there’s a growing framework for research, production, and commercialization. Regulatory support for cannabinoid research and product development fosters innovation in formulations and applications. This regulatory shift not only expands market access but also boosts investor confidence, encouraging more significant investments in research and development. For example, countries like Canada and certain states in the USA have established frameworks that permit controlled cultivation and extraction of minor cannabinoids, paving the way for a diverse range of products targeting specific health benefits.
• Increasing Consumer Awareness and Demand for Natural Therapies: As awareness grows about the potential therapeutic effects of cannabinoids like CBG, CBC, and CBN, consumers are seeking alternatives to traditional pharmaceuticals for conditions such as chronic pain, anxiety, and inflammation. The shift towards holistic wellness and the preference for natural ingredients further supports this trend. Companies are responding by developing a wide array of products, including oils, capsules, and topical formulations that leverage minor cannabinoids’ purported health benefits. Marketing efforts highlighting the unique properties of these compounds and their potential to complement or replace existing treatments are also fueling market growth. This trend towards natural therapies aligns with broader consumer preferences for sustainable and plant-based health solutions, driving expansion in the minor cannabinoids market.

Tetrahydrocannabivarin (THCV) by product type category have emerged as a dominant segment in the global minor cannabinoids market due to its unique properties and potential health benefits.

Unlike THC, THCV is known for its potential appetite-suppressing effects, which makes it appealing for weight management and metabolic health products. This distinct profile has garnered significant interest from consumers seeking alternative treatments for conditions such as obesity and diabetes. Moreover, THCV’s pharmacological effects also include potential anticonvulsant and neuroprotective properties, making it a target for research into treatments for neurological disorders like Parkinson’s disease. Its versatility in addressing multiple health concerns positions THCV as a valuable ingredient in pharmaceutical formulations and wellness products. As regulatory environments become more favorable towards cannabis research and product development, the market for THCV-containing products is expected to expand further, driven by both consumer demand and scientific exploration of its therapeutic potential.

In 2023, nutraceuticals segment solidified its position as the second-largest application category within the global minor cannabinoids market.

This growth is driven by increasing consumer interest in natural health supplements and the perceived health benefits of minor cannabinoids like CBG, CBC, and others. Nutraceutical products incorporating minor cannabinoids are gaining popularity for their potential to support wellness and manage various health conditions without the psychoactive effects associated with THC. Key factors contributing to the segment’s growth include advancements in extraction technologies, which enable efficient isolation and formulation of minor cannabinoids into dietary supplements and functional foods.

Additionally, growing research supporting the therapeutic properties of these cannabinoids, such as anti-inflammatory and antioxidant effects, enhances their appeal in nutraceutical formulations targeting specific health concerns like pain relief, stress management, and skin health. As regulatory frameworks continue to evolve favorably towards cannabis-derived products, the nutraceuticals segment is poised for further expansion, offering opportunities for innovation and market diversification across global markets.

In 2023, North America solidified its dominance in the global minor cannabinoids market, contributing a revenue share of 34.7%.

This dominance can be attributed to several factors, including the progressive legalization of cannabis for both medicinal and recreational purposes across various states and provinces. The region’s well-established infrastructure for cannabis cultivation, extraction, and product development also plays a crucial role in supporting market growth. Furthermore, the presence of a robust healthcare system and growing consumer acceptance of cannabinoid-based therapies contribute to the market’s expansion in North America.

Companies in the region are increasingly investing in research and development to explore the therapeutic potential of minor cannabinoids beyond THC and CBD, driving innovation in product formulations and applications. As regulatory frameworks continue to evolve, providing clearer pathways for market entry and product commercialization, North America is expected to maintain its leadership in the global minor cannabinoids market, offering substantial opportunities for growth and investment.

Competitive Landscape

Some of the players operating in the minor cannabinoids market are

• Aurora Europe GmbH
• BulKanna
• INC.
• Fresh Bros Hemp Company
• GCM Holdings, LLC (Global Cannabinoids)
• High Purity Natural Products.
• Laurelcrest
• Mile High Labs
• PBG Global
• Rhizo Sciences
• ZERO POINT EXTRACTION, LLC
• Other Industry Participants

Global Minor Cannabinoids Market Scope

Global Minor Cannabinoids Market

By Product Type

• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Cannabinol (CBN)
• Cannabidivarin (CBDV)
• Tetrahydrocannabutol (THCB)
• Tetrahydrocannabivarin (THCV)
• Tetrahydrocannabiphorol (THCP)
• Others

By Application

• Pharmaceutical
  • Pain Management
  • Mental Health
  • Sleep Disorders
  • Anti-inflammatory
  • Others
• Nutraceuticals
• Cosmetics and Personal Care
• Food and Beverages
• Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Report Layout:

Table of Contents

.

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

Global Minor Cannabinoids Market

By Product Type

• Cannabigerol (CBG)
• Cannabichromene (CBC)
• Cannabinol (CBN)
• Cannabidivarin (CBDV)
• Tetrahydrocannabutol (THCB)
• Tetrahydrocannabivarin (THCV)
• Tetrahydrocannabiphorol (THCP)
• Others

By Application

• Pharmaceutical
  • Pain Management
  • Mental Health
  • Sleep Disorders
  • Anti-inflammatory
  • Others
• Nutraceuticals
• Cosmetics and Personal Care
• Food and Beverages
• Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.